Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
National Vision
EYE
$1.81B
| $2.45M | ﹤0.01% |
47,916
-33,392
| -41% | -$1.64M |
|
2052
Exponent
EXPO
$3.24B
| $2.45M | ﹤0.01% |
27,432
-36,858
| -57% | -$3.45M |
|
|
MSGN
2053
DELISTED
MSG Networks Inc.
MSGN
| $2.45M | ﹤0.01% |
167,772
+117,105
| +231% | +$1.82M |
|
2054
Gold Fields
GFI
$36.5B
| $2.43M | ﹤0.01% |
273,416
-52,497
| -16% | -$544K |
|
2055
iShares Future Exponential Technologies ETF
XT
$3.97B
| $2.43M | ﹤0.01% |
+38,413
| New | +$2.37M |
|
|
BLUE
2056
DELISTED
bluebird bio
BLUE
| $2.42M | ﹤0.01% |
5,837
+2,038
| +54% | +$807K |
|
2057
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
| $2.42M | ﹤0.01% |
17,707
+1,607
| +10% | +$217K |
|
2058
OceanFirst Financial
OCFC
$1.91B
| $2.42M | ﹤0.01% |
115,838
+16,164
| +16% | +$362K |
|
2059
iShares MSCI Netherlands ETF
EWN
$637M
| $2.41M | ﹤0.01% |
+49,744
| New | +$2.42M |
|
2060
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.23B
| $2.41M | ﹤0.01% |
+42,382
| New | +$2.38M |
|
|
MDRX
2061
DELISTED
Veradigm Inc. Common Stock
MDRX
| $2.41M | ﹤0.01% |
130,123
-108,291
| -45% | -$1.82M |
|
2062
PUT
iShares MSCI Hong Kong ETF
EWH
$1.22B
| $2.4M | ﹤0.01% |
90,000
| – | – |
|
2063
FormFactor
FORM
$9.17B
| $2.4M | ﹤0.01% |
65,720
-49,081
| -43% | -$1.93M |
|
2064
iShares MSCI USA Min Vol Factor ETF
USMV
$24.2B
| $2.4M | ﹤0.01% |
32,534
-297,113
| -90% | -$21.5M |
|
|
RAVN
2065
DELISTED
Raven Industries Inc
RAVN
| $2.39M | ﹤0.01% |
41,300
-3,257
| -7% | -$142K |
|
|
BBT
2066
Beacon Financial Corp
BBT
$2.66B
| $2.38M | ﹤0.01% |
86,850
-6,769
| -7% | -$172K |
|
2067
SPS Commerce
SPSC
$2.64B
| $2.37M | ﹤0.01% |
23,778
-24,111
| -50% | -$2.38M |
|
2068
Pricesmart
PSMT
$5.46B
| $2.36M | ﹤0.01% |
25,939
-7,973
| -24% | -$711K |
|
2069
Magnachip Semiconductor
MX
$145M
| $2.36M | ﹤0.01% |
98,869
+84,640
| +595% | +$2.08M |
|
2070
Vericel Corp
VCEL
$2.31B
| $2.36M | ﹤0.01% |
44,919
-45,834
| -51% | -$2.61M |
|
2071
Replimune Group
REPL
$1.01B
| $2.35M | ﹤0.01% |
61,191
-22,609
| -27% | -$773K |
|
2072
Iovance Biotherapeutics
IOVA
$2.87B
| $2.35M | ﹤0.01% |
90,263
+21,869
| +32% | +$568K |
|
2073
Korn Ferry
KFY
$4.28B
| $2.35M | ﹤0.01% |
32,397
-62,925
| -66% | -$4.18M |
|
2074
PUT
Wolfspeed
WOLF
$1.71B
| $2.35M | ﹤0.01% |
+24,000
| New | +$2.42M |
|
|
APLS
2075
DELISTED
Apellis Pharmaceuticals
APLS
| $2.35M | ﹤0.01% |
37,119
-54,915
| -60% | -$2.83M |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.